1. Home
  2. LXU vs TBPH Comparison

LXU vs TBPH Comparison

Compare LXU & TBPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LXU
  • TBPH
  • Stock Information
  • Founded
  • LXU 1968
  • TBPH 2013
  • Country
  • LXU United States
  • TBPH United States
  • Employees
  • LXU N/A
  • TBPH N/A
  • Industry
  • LXU Major Chemicals
  • TBPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • LXU Industrials
  • TBPH Health Care
  • Exchange
  • LXU Nasdaq
  • TBPH Nasdaq
  • Market Cap
  • LXU 612.4M
  • TBPH 699.0M
  • IPO Year
  • LXU 1969
  • TBPH N/A
  • Fundamental
  • Price
  • LXU $8.51
  • TBPH $14.54
  • Analyst Decision
  • LXU Buy
  • TBPH Strong Buy
  • Analyst Count
  • LXU 3
  • TBPH 4
  • Target Price
  • LXU $10.17
  • TBPH $23.00
  • AVG Volume (30 Days)
  • LXU 432.6K
  • TBPH 286.7K
  • Earning Date
  • LXU 10-29-2025
  • TBPH 11-10-2025
  • Dividend Yield
  • LXU N/A
  • TBPH N/A
  • EPS Growth
  • LXU N/A
  • TBPH N/A
  • EPS
  • LXU N/A
  • TBPH 0.26
  • Revenue
  • LXU $585,065,000.00
  • TBPH $77,205,000.00
  • Revenue This Year
  • LXU $12.10
  • TBPH $79.82
  • Revenue Next Year
  • LXU N/A
  • TBPH N/A
  • P/E Ratio
  • LXU N/A
  • TBPH $57.30
  • Revenue Growth
  • LXU 12.49
  • TBPH 24.49
  • 52 Week Low
  • LXU $4.88
  • TBPH $7.90
  • 52 Week High
  • LXU $9.85
  • TBPH $15.15
  • Technical
  • Relative Strength Index (RSI)
  • LXU 47.60
  • TBPH 63.56
  • Support Level
  • LXU $8.21
  • TBPH $14.11
  • Resistance Level
  • LXU $9.85
  • TBPH $14.42
  • Average True Range (ATR)
  • LXU 0.45
  • TBPH 0.41
  • MACD
  • LXU -0.07
  • TBPH 0.04
  • Stochastic Oscillator
  • LXU 18.29
  • TBPH 89.80

About LXU LSB Industries Inc.

LSB Industries Inc is engaged in the manufacturing and sale of chemical products in the United States. The company manufactures and sells chemical products for the agricultural and industrial sectors. Its products include ammonia, fertilizer grade ammonium nitrate (AN and HDAN), and urea ammonia nitrate (UAN) for agricultural applications; high purity and commercial grade ammonia, sulfuric acids, concentrated, blended, and regular nitric acid, mixed nitrating acids, carbon dioxide, and diesel exhaust fluid for industrial applications; and industrial grade AN (LDAN) and AN solutions for mining applications. Its products are sold through distributors and directly to end customers throughout the United States and other parts of North America.

About TBPH Theravance Biopharma Inc.

Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

Share on Social Networks: